Siglec-6 on chronic lymphocytic leukemia cells is a target for post-allogeneic hematopoietic stem cell transplantation antibodies

Overview of attention for article published in Cancer Immunology Research, September 2018

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (76th percentile)
Good Attention Score compared to outputs of the same age and source (70th percentile)

Mentioned by

twitter: 3 X users
patent: 2 patents

wikipedia: 1 Wikipedia page

Citations

dimensions_citation: 10 Dimensions

Readers on

mendeley: 23 Mendeley

Summary X Patents Wikipedia Dimensions citations

So far, Altmetric has seen 2 patents that reference this research output.

ANTI-SIGLEC-6 ANTIBODIES AND METHODS OF USE THEREOF

Application WO-2023044390-A1

World Intellectual Property Organisation (WIPO)

SIGLEC-6-BINDING POLYPEPTIDES

Application WO-2022034022-A1

World Intellectual Property Organisation (WIPO)

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity.